ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL)
NCT: NCT07686627 · COMPLETED
Brief Summary
This study evaluated the effects of ShotBlocker and a warm gel pack on pain, comfort, and physiological parameters during heel prick testing in healthy term newborns. A three-arm randomized controlled trial was conducted at a city hospital between October 2025 and May 2026. Newborns were randomly assigned to the ShotBlocker group, warm gel pack group, or routine care group. Pain was assessed using the Neonatal Infant Pain Scale (NIPS), and comfort was assessed using the Neonatal Comfort Behavior Scale (NCBS). Heart rate, respiratory rate, oxygen saturation, and heel temperature were also measured before and after the procedure. The study aimed to compare the effectiveness of these non-pharmacological interventions during routine heel prick testing.
Frequently Asked Questions
What is ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL)?
ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL) is a clinical trial registered under NCT07686627. Current status: COMPLETED.
What is the status of NCT07686627?
The current status of NCT07686627 (ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL)) is: COMPLETED.
When did ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL) start?
ShotBlocker and Warm Gel Pack During Neonatal Heel Prick (HEAL) started on 2025-10-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.